EUVIMEDSkopri EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY 4.0

Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta‐analysis

Nipun Lakshitha de Silva, Harsha Dissanayake, Camila Suarez, Ranga Eshaka Wickramarachchi, Ranjith Ramasamy iD, Waljit S Dhillo, Suks Minhas, Giovanni Corona iD, Channa N Jayasena iD

Andrology · 2024

DOI: 10.1111/andr.13480 ↗

At a glance

Metaanalyse in Andrology, 2024. Written by Nipun Lakshitha de Silva and 8 co-authors. Institution: Faculty of Medicine, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka. Major MEDLINE topics: Aromatase Inhibitors, Hypogonadism. Cited 7 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Selective oestrogen receptor modulators and aromatase inhibitors stimulate endogenous gonadotrophins and testosterone in men with hypogonadism. There are no systematic reviews/meta‐analyses assessing the effects of selective oestrogen receptor modulators/aromatase inhibitors on semen parameters in men with secondary hypogonadism.

Objectives

To assess the effect of monotherapy or a combination of selective oestrogen receptor modulators/aromatase inhibitors on sperm parameters and/or fertility in men with secondary hypogonadism. Materials and methods A systematic search was conducted in PubMed, MEDLINE, Cochrane Library and ClinicalTrials.gov. Study selection and data extraction were performed by two reviewers independently. Randomised controlled trials and non‐randomised studies of interventions reporting effects of selective oestrogen receptor modulators and/or aromatase inhibitors on semen parameters or fertility in men with low testosterone with low/normal gonadotrophins were selected. The risk of bias was assessed using ROB‐2 and ROBINS‐I tools. The results of randomised controlled trials were summarised using vote counting while summarising effect estimates where available. Non‐randomised studies of intervention meta‐analysis were conducted using the random‐effect model. The certainty of evidence was assessed using GRADE.

Results

Five non‐randomised studies of interventions ( n = 105) of selective oestrogen receptor modulators showed an increase in sperm concentration (pooled mean difference 6.64 million/mL; 95% confidence interval 1.54, 11.74, I 2 = 0%) and three non‐randomised studies of interventions ( n = 83) of selective oestrogen receptor modulators showed an increase in total motile sperm count (pooled mean difference 10.52; 95% confidence interval 1.46–19.59, I 2 = 0%), with very low certainty of evidence. The mean body mass index of participants was >30 kg/m 2 . Four randomised controlled trials ( n = 591) comparing selective oestrogen receptor modulators to placebo showed a heterogeneous effect on sperm concentration. Three included men with overweight or obesity. The results were of very low certainty of evidence. Limited pregnancy or live birth data were available. No studies comparing aromatase inhibitors with placebo or testosterone were found. Discussion and conclusion Current studies are of limited size and quality but suggest that selective oestrogen receptor modulators may improve semen parameters in those patients, particularly when associated with obesity.

Subjects

MeSH terms (MEDLINE)

Aromatase InhibitorsHypogonadismPregnancyFemaleHumansMaleSemenSelective Estrogen Receptor ModulatorsTestosteroneEstrogensObesity

Author keywords

aromatase inhibitorsfertilityhypogonadotropic hypogonadismsecondary hypogonadismselective oestrogen receptor modulatorsspermatogenesis

Substances

Aromatase InhibitorsSelective Estrogen Receptor ModulatorsTestosteroneEstrogens

Authors and institutions

  • Faculty of Medicine, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka.
  • Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
  • Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Section of Investigative Medicine, Imperial College London, London, UK.
  • Department of Urology, Imperial College NHS Healthcare, London, UK.
  • Endocrinology Unit, Medical Department, Azienda USL, Maggiore-Bellaria Hospital, Bologna, Italy.

ORCID profiles: Ranjith Ramasamy, Giovanni Corona, Channa N Jayasena

Cite

APA

de Silva, N. L., Dissanayake, H., Suarez, C., Wickramarachchi, R. E., Ramasamy, R., Dhillo, W. S., Minhas, S., Corona, G., & Jayasena, C. N. (2024). Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta‐analysis. Andrology. https://doi.org/10.1111/andr.13480

Vancouver

de Silva NL, Dissanayake H, Suarez C, Wickramarachchi RE, Ramasamy R, Dhillo WS, et al. Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta‐analysis. Andrology. 2024. doi:10.1111/andr.13480

BibTeX
@article{deSilva2024,
  author = {de Silva, Nipun Lakshitha and Dissanayake, Harsha and Suarez, Camila and Wickramarachchi, Ranga Eshaka and Ramasamy, Ranjith and Dhillo, Waljit S and Minhas, Suks and Corona, Giovanni and Jayasena, Channa N},
  title = {Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta‐analysis},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13480}
}
Start for free →